MARK2 and gastric cancer: In addition, tumor inhibitory functions of miR-377-3p were demonstrated in pancreatic cancer by regulating a serine/threonine kinase, namely Pim-3 proto-oncogene [19], and in gastric cancer through reducing the level of vascular endothelial growth factor A (VEGFA) [20].